Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

RainTree Oncology Services

Explore full profile

RainTree Oncology Services

San Diego, United StatesFounded 2011Biotech & Life Sciences
Valuation $0–100M Latest valuation · 2012
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for RainTree Oncology Services and the history behind them.

About RainTree Oncology Services

RainTree Oncology Services operates as a national group purchasing organization (GPO) and alliance for community oncology practices across the United States. The company was founded in 2011 by Dr. Jeffrey Patton, who served as its Chief Medical Officer, alongside other executives who had previously been with AmerisourceBergen's ION group. Dr. Patton, a board-certified hematologist and oncologist with extensive experience in clinical trial research, also held the role of CEO at Tennessee Oncology for a decade, bringing a deep, physician-led perspective to RainTree's mission of supporting community-based cancer care.

Read full description

The firm's business model is centered on empowering independent oncology practices to remain competitive and efficient. It achieves this by negotiating favorable purchasing contracts for pharmaceuticals, particularly oral oncolytics, and other necessary supplies, thereby leveraging the collective buying power of its members. RainTree also provides a suite of technology and support services to its member clinics. These include practice management tools, data analytics platforms to evaluate care pathways, and inventory management systems. This integrated approach helps practices improve operational efficiency, manage costs, and enhance patient care. A key component of its offering is assisting practices in establishing and operating on-site pharmacies, which provides patients with convenient access to medications and creates a new revenue stream for the practices.

RainTree serves community oncology practices, which are responsible for treating the majority of cancer patients in the U.S. The company's revenue is generated through the administration of GPO contracts and by providing its suite of management, technology, and pharmacy services to its network of members. Over the years, RainTree established significant partnerships, including collaborations with Express Scripts to launch a pharmacy network and with Cardinal Health, which became its exclusive distributor and GPO administrator for specialty medications in 2015 before acquiring the company in March 2016. The acquisition was a strategic move by Cardinal Health to expand its specialty distribution footprint, particularly in the growing oral oncology market.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2011
Headquarters
San Diego, United States
Open positions
None listed
Dealroom signal
24.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Supply Chain Management, Risk Management, Retail, Biotechnology, Oncology, Patient Care, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning RainTree Oncology Services.

See all news

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONExit Mar 2016 $0 Cardinal Health
LATE VCEquity / VC Aug 2012 $23M $91M Undisclosed
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

RainTree Oncology Services website traffic

Latest recorded traffic for RainTree Oncology Services is 320 monthly website visits.

Latest monthly visits320
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
DiagnotesConnecting Health Care Teams For More Effective Communication | Diagnotes | Diagnotes | Patient Care. Anywhere. Indianapolis, United States Operational 13 $2M $4M
Merrimack PharmaceuticalsMerrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer Cambridge, United States Operational
DiaCartaImproving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS Hayward, United States Operational
Omthera PharmaceuticalsDevelops therapies for patients with elevated triglyceride levels and increased risk of cardiovascular disease Princeton, United States Acquired
OrgenesisDeveloping and manufacturing cell-therapy solutions Tel Aviv-Yafo, Israel Operational
Kiadis PharmaEngaged in the clinical development and commercialization of cell-based immunotherapy products for treatment of blood cancer and blood disorders Amsterdam, Netherlands Acquired
CliniCastCliniCast enables value-based, patient-centered oncology care and helps healthcare organizations improve outcomes San Francisco, United States Operational
Atossa GeneticsHealthcare company developing cellular and molecular diagnostic risk assessment products for breast cancer patients Seattle, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Other known investors1 additional known investor

  • Cardinal Health
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · San Diego HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about RainTree Oncology Services on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See RainTree Oncology Services’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.